Porton Pharma Solutions, a China-based contract development and manufacturing organization (CDMO), has started construction of a new, state-of-the-art crystallization and drug product facility in Cranbury, NJ. The new building is projected to open in the fourth quarter of 2022. This facility will be cGMP capable for drug product supplies, and will expand the company’s ability to offer integrated drug substance (DS) and drug product (DP) R&D services and early clinical supplies to its client ...